Neutrophil to lymphocyte ratio does not behave as a good predictor of pathological complete response in breast cancer: A retrospective analysis in the neoadjuvant setting
Authors:
- Giovana Diniz de Oliveira BonettiGBGiovana Diniz de Oliveira Bonetti
- Vitória de Oliveira XimendesVXVitória de Oliveira Ximendes
- Cristhian Ferreira FalleiroCFCristhian Ferreira Falleiro
- Lidielle Oliveira de MoraisLMLidielle Oliveira de Morais
- Luiza Trisch da SilvaLSLuiza Trisch da Silva
- Mariana Severo DebastianiMDMariana Severo Debastiani
- Rafael José Vargas AlvesRARafael José Vargas Alves
- Claudia Giuliano BicaCBClaudia Giuliano Bica
Open Access
- 17 November 2023
- journal article
- research article
- Published by Elsevier in Advances in Cancer Biology - Metastasis
- Vol. 9
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in HER2-Positive Metastatic Breast CancerCurrent Oncology, 2022
- Predictive value of neutrophil-to-lymphocyte-ratio in neoadjuvant-treated patients with breast cancerArchives of Gynecology and Obstetrics, 2022
- Pretreatment Leukocyte Count Ratios as Metastatic Predictive Factors in Luminal Type Breast CancerAsian Pacific Journal of Cancer Prevention, 2022
- Derived Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast CancerFrontiers in Oncology, 2022
- Platelet-to-Lymphocyte Ratio Is Associated With Favorable Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Study on 120 PatientsFrontiers in Oncology, 2021
- Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant SettingCells, 2021
- Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapyBMC Cancer, 2021
- Biomarkers of neoadjuvant/adjuvant chemotherapy for breast cancerChinese Clinical Oncology, 2020
- Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysisClinical Cancer Research, 2020
- The Neutrophil to Lymphocyte Ratio Predicts the Response to Neoadjuvant Chemotherapy in Luminal B Breast CancerAsian Pacific Journal of Cancer Prevention, 2019